Slow-Release Oral Morphine for the Treatment of Opioid Use Disorder

NCT03948464 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

27

Enrollment

OTHER

Sponsor class

Stopped Study unable to proceed per protocol due to COVID-19 precautions

Conditions

Opioid-Related Disorders
Opiate Substitution Treatment
Morphine
Methadone
Fentanyl

Interventions

DRUG: Slow release oral morphine (SROM)
DRUG: Methadone

Sponsor

M. Eugenia Socias

Collaborators

[object Object]
[object Object]
[object Object]